Stay alert, beware of scamsters - know more

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open1,016
High1,016.9
Low994.1
Prev. Close997
Avg. Traded Price1,004.44
Volume13,20,461

MARKET DEPTH

info2
Total bid37.00
Total ask0.00
OrdersQtyBid
337997
000
000
000
000
AskQtyOrders
000
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

994.106 hours ago
1016.9012 hours ago
arrow

LOWER/UPPER CIRCUITS

913.00
1115.80
arrow
Max Healthcare Ins Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 18.82%, in the last year to ₹8,536.07 Cr. Its sector's average revenue growth for the last fiscal year was 20.05%.
noteAnnual Net Profit,rose 34.07% in the last year to ₹1,442.41 Cr. Its sector's average net profit growth for the last fiscal year was -20.19%.
noteQuarterly Revenue,rose 16.7% YoY to ₹2,406.69 Cr. Its sector's average revenue growth YoY for the quarter was 26.16%.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : %
Net profit growth 5Y CAGR : %

STOCK RETURNS

info
Versus Nifty 50
1 w
-5.65%
vs
-0.89%
1 mth
-7.46%
vs
+0.13%
3 mth
-4.72%
vs
+3.03%
6 mth
-6.28%
vs
-5.28%
1 yr
-16.75%
vs
-2.05%
3 yr
+86.19%
vs
+25.82%
5 yr
+193.62%
vs
+46.65%

About the Max Healthcare Institute Limited

Max Healthcare Institute Limited is one of India’s leading private hospital networks with a 25-year history of delivering tertiary and quaternary care. As on March 31, 2025, the network comprised 22 healthcare facilities with a capacity of over 5,100 beds, supported by advanced technologies and multidisciplinary clinical teams. Beyond hospitals, the Company’s ecosystem includes Max@Home (home healthcare) across 15+ cities and Max Lab (diagnostics) in 50+ cities, expanding access to care beyond traditional settings. Its clinical strengths span oncology, cardiac sciences, neurosciences, orthopaedics, renal sciences, transplants and more, with robotic surgery and modern imaging platforms deployed across the network.

Geographically, Max Healthcare serves patients across Delhi NCR (including Saket, Rajendra Place, Patparganj, Shalimar Bagh, Dwarka, Vaishali, Gurugram, Panchsheel Park, Noida and Lajpat Nagar) as well as Mumbai, Mohali, Bathinda, Dehradun, Lucknow and Nagpur. The Group had 10 subsidiaries as on March 31, 2025, including one step-down subsidiary.

 

Business Segment of Max Healthcare Institute Limited

  • Oncology – 25.8% of revenue in FY 2024-25

  • Cardiac Sciences – 10.7% of revenue

  • Orthopaedics – 10.4% of revenue

 

Max Healthcare Institute Limited’s Key Management Team

  • Abhay Soi – Chairman and Managing Director

  • Yogesh Kumar Sareen – Senior Director and Chief Financial Officer

  • Dhiraj Aroraa – Senior Vice President – Company Secretary and Compliance Officer

  • Dr Sandeep Budhiraja – Group Medical Director

  • Dr Vivek Talaulikar – Director and Chief Operating Officer (Western Region)

  • Dr Mradul Kaushik – Senior Director – Operations and Planning and Chief Operating Officer (Cluster 1)

  • Col. Harinder Singh Chehal – Senior Director – Chief Operating Officer (Cluster 2)

  • Umesh Gupta – Senior Director – HR and Chief People Officer

  • Anas Abdul Wajid – Senior Director – Chief Sales and Marketing Officer

  • Gagan Palta – Director & General Counsel

 

Latest Updates on Max Healthcare Institute Limited

  • Inorganic expansion: The Company acquired Jaypee Healthcare Limited, making Max Super Speciality Hospital, Noida part of the network; Max Super Speciality Hospital, Dwarka commenced operations as an asset-light greenfield model.

  • Capacity pipeline: A new greenfield hospital is under development in Sector 56, Gurugram, with additional built-to-suit facilities planned in Mohali (Zirakpur), Thane and Pitampura; multiple brownfield bed additions are underway across Mohali, Mumbai, Saket, Patparganj, Lucknow, Nagpur, Dwarka, Vaishali and Noida.

  • Network scale and reach: As of March 31, 2025, the network stood at 22 facilities with over 5,100 beds; Max@Home operated in 15+ cities and Max Lab in 50+ cities, extending patient-centric services beyond hospitals.

  • Accreditations and awards: The network includes four JCI-accredited hospitals and multiple AACI/NABL/QAI recognitions; facilities and teams received honours such as Best Patient-centric Hospital and Best Oncology Centre during 2024–25.

External rating: CARE Ratings reaffirmed the Company’s long-term rating at CARE AA+ and short-term rating at CARE A1+.

personal

Grow your wealth with more research recommendations

+91

Frequently Asked Questions

As of 19 Aug 2026, the share price of Max Healthcare Ins Ltd is ₹997.00 on the NSE and ₹996.45 on the BSE. The stock opened at ₹1,000.70, touched a high of ₹1,022.60 and a low of ₹982.10 during today's session.

Over the last 6 months, Max Healthcare Ins Ltd has given a return of -6.20%. The stock was priced at ₹1,081.45 on 19 Feb 2026 and has Fallen to ₹997.00 as of 19 Aug 2026, a change of ₹84.45 per share.

Max Healthcare Ins Ltd has delivered -17.49% return over the last 52 weeks. During this period, the stock hit a 52-week high of ₹1,256.00 on 21 Aug 2025 and a 52-week low of ₹903.00 on 07 Apr 2026. It is currently trading at ₹997.00 as of 19 Aug 2026.

The all-time high (ATH) for Max Healthcare Ins Ltd was ₹1,301.40, recorded on 03 Jul 2025. At the current price of ₹997.00, the stock is trading 23.39% below its all-time high. The all-time low recorded was ₹103.65 on 29 Oct 2020.

Max Healthcare Ins Ltd has delivered a return of -5.09% over the last 3 months. The stock was trading at ₹1,068.75 on 19 May 2026 and is currently at ₹997.00 as of 19 Aug 2026, reflecting a Loss of ₹71.75 per share over this period.

Max Healthcare Ins Ltd has delivered a 207.72% absolute return over the past 5 years, equivalent to a CAGR of 25.21% per annum. The stock was priced at ₹324.00 in Aug 2021 and has risen to ₹997.00 as of 19 Aug 2026. An investment of ₹1,00,000 in Max Healthcare Ins Ltd five years ago would be worth ₹3,07,720.00 today.

No,Max Healthcare Ins Ltd has not declared any dividend over the past 5 years. The company paid a total dividend of 6.00 per share between FY2022 and FY2026, with the most recent dividend of ₹2.00 per share for May 26, with an ex-dividend date of 03 Jul 2026. At the current market price of ₹997.00, the trailing dividend yield of Max Healthcare Ins Ltd stands at 3.50%.

The intraday high for Max Healthcare Ins Ltd on the NSE today (19 Aug 2026) was ₹1,022.60. This compares to the 52-week high of ₹1,256.00 recorded on 21 Aug 2025. Today's high was -18.58% below the 52-week high.

The intraday low for Max Healthcare Ins Ltd on the NSE today was ₹982.10. The stock's 52-week low stands at ₹903.00, recorded on 07 Apr 2026. Today's low is 8.76% above the 52-week low, indicating the stock is trading well above its yearly lows.

For Q1 FY27, Max Healthcare Ins Ltd reported: Revenue (Net Sales): ₹8682.50 Cr - Up 6.17% year-on-year from ₹8177.70 Cr in Q4 FY26. Net Income (PAT): ₹1676.00 Cr - Down -17.52% year-on-year from ₹2032.10 Cr in Q4 FY26.

+91
Offer Banner Trigger
Offer Banner

Open a FREE Demat Account

+91